Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

New treatments for PCOS focus on managing symptoms and improving fertility.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Male pattern baldness involves genetics, hormones, and needs better treatments.

PCOS starts in adolescence with hormonal issues, leading to adult health problems, and early treatment is crucial.

Some women with acne have higher levels of free testosterone, which might suggest using hormonal treatments for acne.

Finasteride and flutamide effectively reduce hirsutism in PCOS women, with flutamide also lowering hormone levels.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Laser hair removal is effective for dark hair but needs improvement for nonpigmented or fine hairs.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

PCOS affects women's health by increasing the risk of diabetes, heart disease, and reproductive issues.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Hair growth is influenced by factors like genetics and nutrition, and more research is needed to understand hair loss and growth mechanisms.

The document concludes that low-dose oral contraceptives and hormonal therapies can manage perimenopause symptoms and reduce some health risks, but lifestyle changes and disease screening are also important.

The article explains how to identify and treat excessive hair growth in women, which can be distressing and may signal other health problems.

Hirsutism causes significant psychological distress in women.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Hair disorders are caused by a complex mix of biology, genetics, hormones, and environmental factors, affecting hair growth and leading to conditions like alopecia.

Post-implantation erythema is a red skin condition after medical device implantation that sometimes goes away on its own.

Alopecia X in dogs is a cosmetic issue, not a hormonal disorder, and harmful treatments should be avoided.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.